Total bilirubin =< 1.5 x upper limit of normal (ULN) (except in subjects with Gilbert syndrome who must have a total bilirubin < 3.0 x ULN)
Total bilirubin =< 1.5 x upper limit of normal (ULN) in absence of Gilbert disease (total bilirubin =< 3 x ULN with Gilbert); also, if hyperbilirubinemia is clearly attributed to liver metastases total bilirubin =< 3 x ULN is permitted
Total bilirubin =< 1.5 x upper limit of normal (ULN) except in the case of Gilbert disease
Total bilirubin =< 1.5 x upper limit of normal (ULN); unless patient has Gilbert disease
Total bilirubin < 1.5 x upper limit of normal (ULN) (or < 3 x ULN for subjects with Gilbert's syndrome)
Total bilirubin =< 1.5 x upper limit of normal (ULN) or 3 x ULN for Gilbert's disease
Bilirubin ? 1.5 times upper limit of normal (x ULN); if liver metastases are present, then ? 2 x ULN is allowed. Criteria does not apply to subjects with Gilbert's syndrome diagnosed as per institutional guidelines.
Total bilirubin at most1.5 x the upper limit of the normal range (ULN), except Gilbert's disease
Total bilirubin must be less than or equal to 1.5 x ULN (upper limit of normal) for the lab unless the patient has a bilirubin elevation greater than 1.5 x ULN to 3 x ULN due to Gilbert's disease or similar syndrome involving slow conjugation of bilirubin; and
Total or direct bilirubin ? 1.5 times upper limit of normal (x ULN); does not apply to subjects with Gilbert's syndrome diagnosed as per institutional guidelines.
Total bilirubin ?1.5 × the upper limit of normal (ULN) (subjects with Gilbert's Syndrome are allowed if direct bilirubin is within normal limits);
Serum bilirubin =< 1.5 × upper limit of normal (ULN); bilirubin =< 3 x ULN is permitted in individuals with documented liver involvement by lymphoma or if due to known Gilbert syndrome
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) or within 3 x the ULN for patients with Gilbert disease
Total bilirubin ?1.5 times the upper limit of normal (ULN) except for unconjugated hyperbilirubinemia of Gilbert's syndrome;
Total serum bilirubin =< 1.5 x upper limit of normal (ULN) OR if hepatic involvement by lymphoma: =< 3 x ULN for Gilbert's disease or documented hepatic involvement by lymphoma
Total bilirubin ? 1.5 x upper limit of institutional normal (ULN), unless due to Gilbert's syndrome
Total bilirubin =< 1.5 X upper limit of normal (ULN), with exception of patients with Gilbert syndrome
Total or direct bilirubin ? 2 times upper limit of normal (x ULN); does not apply to subjects with Gilbert's syndrome diagnosed as per institutional guidelines.
Total bilirubin ?2.0 x the upper limit of normal or <3.0 xULN if patient has a history of Gilbert's syndrome
Total bilirubin =< 1.5 upper limit of normal (ULN), with the exception of patients with Gilbert syndrome
Total bilirubin >1.5 x upper limit of normal (ULN). For patients with Gilbert's syndrome, total bilirubin >2.5 x ULN.
Total bilirubin =< 1.5 X institutional upper limit of normal (ULN) unless due to indirect hyperbilirubinemia related to Gilbert's syndrome or hemolysis, or to disease infiltration
Total bilirubin ? 1.5 x upper limit of normal (ULN) (Patients with documented diagnosis of Gilbert syndrome are eligible if total bilirubin < 3.0 x ULN)
Total bilirubin =< 3 X upper limit of normal (ULN), unless attributable to Gilbert syndrome
Total Bilirubin ? 1.5 x upper limit of normal (ULN), or patients diagnosed with Gilbert's syndrome, that have been reviewed and approved by the medical monitor
Total bilirubin ? 1.5 × upper limit of normal (ULN) (unless indirect bilirubin is elevated due to Gilbert's syndrome or hemolysis)
Bilirubin less than or equal to 2.5 x the upper limit of normal (ULN) (excluding Gilbert's syndrome)
Bilirubin < 1.5 x institutional upper limit of normal (ULN) or < 3 x ULN in patients with Gilbert's disease or liver involvement
Total bilirubin =< 3 X upper limit of normal (ULN) (except subjects with Gilbert syndrome, who can have total bilirubin up to 3.5 X ULN)
Total bilirubin =< 1.5 x upper limit of normal (ULN); =< 3 x ULN for patients with known Gilbert disease.
Bilirubin ?1.5 times the upper limit of normal (ULN) unless due to Gilbert Syndrome
Total bilirubin ? 1.5 X upper limit of normal (ULN) for current age (? 3 X ULN if increase in bilirubin is attributable to Gilbert's Syndrome)
Total bilirubin < 2.5 x upper limit of institutional normal reference range; patients with known Gilbert disease who have serum bilirubin =< 3 x upper limit of normal (ULN) may be enrolled
Bilirubin < 1.5 x institutional upper limit of normal (ULN) or < 3 x ULN in patients with Gilbert's disease or liver involvement
Total bilirubin < 1.5 x institutional upper limit of normal (with the exception of those with Gilbert syndrome
Total bilirubin =< 1.5 X upper limit of normal (ULN), for patients with congenital unconjugated hyperbilirubinemia (Crigler-Najjar syndrome type 1 and 2, Gilbert syndrome) that transient hyperbilirubinemia can occur due to physiological condition, as long as there is clear documentation of diagnosis, allowed to be enrolled if direct (conjugated) bilirubin is 1.5 X ULN
Total bilirubin < 2 x upper limits of normal (ULN) except Gilbert syndrome where < 3 x ULN is allowed
Total bilirubin =< 1.5 × institutional upper limit of normal (except for patients with Gilbert disease)
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (except patients with Gilbert syndrome or liver metastasis who can have total bilirubin < 3.0 x ULN)
Total bilirubin =< 1.5 x upper limit of normal (ULN) except for patients with known Gilbert syndrome
Total bilirubin =< 1.5 X upper limit of normal (ULN), with the exception of patients with Gilbert syndrome who are required to have =< 3 X ULN
Total bilirubin =< 1.5 x upper limit of normal (ULN); for subjects with documented/suspected Gilbert's disease, bilirubin =< 3 x ULN
Total bilirubin =< 2.0 x upper limit of normal (ULN) (unless elevated bilirubin is related to Gilbert syndrome), within 14 day prior to registration
Total bilirubin =< 1.5 x upper limit of normal (ULN) (unless due to Gilbert syndrome, in which case it should be =< 3.0 x ULN)
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN), in case of Gilbert's syndrome, =< 2 x ULN within 30 days prior to C1D1
Total bilirubin ? 2 times the upper limit of normal (ULN) unless due to Gilbert's disease
Total bilirubin ?1.5 x upper limit of normal (ULN) (except patients with documented Gilbert's syndrome);
Liver: total bilirubin ? 1.5 x the upper limit of normal (ULN; unless known Gilbert's syndrome); alanine aminotransferase ? 2.5 x ULN (? 5.0 x ULN in patients with liver metastases).
Total bilirubin > 1.5 times upper limit of normal (ULN) unless an alternate nonmalignant etiology exists (e.g., Gilbert's disease)
Total bilirubin >1.5 x upper limit of normal (ULN). For patients with Gilbert's syndrome total bilirubin >2.5 x upper limit of normal (ULN)
Total bilirubin < 2 x upper limits of normal (ULN) except Gilbert’ syndrome where < 3 x ULN is allowed
Serum total bilirubin =< 1.5 x upper limit of normal (ULN) (except for patients with documented Gilbert's syndrome)
Total bilirubin > 1.5 x upper limit of normal (ULN) unless related to Gilbert's syndrome or hemolysis
Total bilirubin < 1.5 x upper limit of normal (ULN) (Gilbert's allowed 3 x ULN)
Total bilirubin =< 2 mg/dl or =< 2.5 x upper limit of normal (ULN) for age (unless Gilbert's syndrome)
Adequate organ function defined as: bilirubin <2x upper limit of normal (ULN) (unless associated with Gilbert's syndrome), and ALT or AST <2.5x ULN.
Serum bilirubin < 2 mg/dL upper limit of normal (unless due to Gilbert's disease; patient with this disease should have a right upper quadrant ultrasound evaluation before treatment)
Total serum bilirubin =< 1.5 x upper limit of normal (ULN), unless due to Gilbert's syndrome
Total bilirubin =< 1.5 x upper limit of normal (ULN) or =< 3 x ULN if documented hepatic involvement with lymphoma, or =< 5 x ULN if history of Gilbert's syndrome, without use of growth factor support for 1 week
Total bilirubin greater the upper limit of normal (ULN; unless the subject has documented Gilbert's syndrome).
Total bilirubin must be less than or equal to 1.5 x ULN (upper limit of normal) for the lab unless the patient has a bilirubin elevation greater than 1.5 x Upper limit of normal (ULN) to 3 x ULN due to Gilbert's disease or similar syndrome involving slow conjugation of bilirubin; and
total bilirubin: ?2 x upper normal limit (UNL) (patients with Gilbert's disease are eligible, hyperbilirubinemia is intermittent & indirect)
To be performed within 14 days prior to day 1 of protocol therapy: total bilirubin =< 1.5 x upper limit of normal (ULN) (=< for Gilbert's syndrome or documented hepatic involvement by lymphoma)
Total bilirubin ? 2 times the upper limit of normal (ULN) unless due to Gilbert's disease
Total bilirubin =< 2 x upper limit of normal (ULN) (unless elevated bilirubin is related to Gilbert syndrome).
Total bilirubin (TBL) =< 1.5 x upper limit of normal (ULN) except patients with documented Gilbert's syndrome (> 3 x ULN), within 28 days of day 0.
Total bilirubin <=<1.5 x the upper limit of normal unless considered due to Gilbert's syndrome
Total bilirubin within normal ranges unless associated with hepatobiliary metastases or Gilbert syndrome, then total bilirubin =< 2 x upper limit of normal (ULN)
Total bilirubin < 1.5 x institutional upper limit of normal (ULN) (except for patients with Gilbert's syndrome and elevations of indirect bilirubin)
Total bilirubin ? 1.5 × upper limit of normal range except in cases of Gilbert's disease and liver metastases.
Serum bilirubin =< 1.5 x upper limit of normal (ULN) unless attributable to Gilbert's syndrome
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (or =< 2.0 x ULN in patients with documented Gilbert's syndrome)
Bilirubin ? 1.5 x upper limit of normal (ULN) except for unconjugated hyperbilirubinemia or Gilbert's syndrome;
Serum bilirubin at least 1.5 × upper limit of normal (ULN) or at least 3 × ULN if Gilbert's disease is documented
Patient has > 1.5 x upper limit of normal (ULN) total bilirubin unless history of Gilbert's syndrome
Total bilirubin less than or equal to 1.5 X the upper limit of normal (ULN) except for unconjugated hyperbilirubinemia of Gilbert's syndrome
Bilirubin < 1.5 X ULN (the upper limit of normal) (subjects with confirmed Gilbert disease as the cause of their elevated bilirubin are to be permitted)
Total bilirubin =< 1.5 x upper limit of normal (ULN) or =< 3 x ULN if documented hepatic involvement with lymphoma, or =< 5 x ULN if history of Gilbert's syndrome
Total bilirubin =< 1.5 x upper limit of normal (ULN, unless due to Gilbert syndrome, in which case it should be =< 3.0 x ULN)
Serum bilirubin =< 1.5 x institutional upper limit of normal (ULN); (unless Gilbert's syndrome, without concurrent clinically significant liver disease), obtained within 14 days prior to first treatment
Bilirubin < 1.5 x upper limit of normal (unless Gilbert's syndrome)
Total bilirubin level <= 1.5 x the upper limit of normal (ULN), unless the patient has known Gilbert's disease
Serum total bilirubin ?1.5 × upper limit of normal (ULN), unless considered due to Gilbert's disease or disease involvement following approval by the Medical Monitor;
Bilirubin ? 1.5 x upper limit of normal (ULN); does not apply to patients with Gilbert's syndrome
Bilirubin < 1.5 x upper limit of normal (ULN) except for unconjugated hyperbilirubinemia or Gilbert's syndrome
Serum bilirubin < 1.5 x upper limit of normal (ULN) (except for patients with documented Gilbert's disease)
Bilirubin less than or equal 1.5 x upper limit of normal (ULN) except for unconjugated hyperbilirubinemia or Gilbert's syndrome
Serum bilirubin =< 1.5 x upper limit of normal (ULN) unless attributable to Gilbert's syndrome
Total bilirubin =< 1.5 X institutional upper limit of normal (unless due to Gilbert's disease)
Serum bilirubin >= 1.5 x upper limit of normal (ULN) or for patients with Gilbert's disease, >= 3 mg/dL at the screening visit
Serum bilirubin =< 1.5 x upper limit of normal (ULN) unless deemed elevated secondary to lymphoma involvement of the liver or known Gilbert's syndrome
Serum bilirubin =< 1.5 x institutional upper limit of normal (ULN) (=< 3 x institutional ULN in patients with Gilbert's syndrome)
Total bilirubin ? 2 × upper limit of normal (ULN) or < 3 x ULN for patients with Gilbert-Meulengracht Syndrome
Serum bilirubin =< 1.5 x institutional upper limit of normal (ULN); (unless Gilbert's syndrome, for which bilirubin =< 3 x institutional upper limit of normal [ULN], without concurrent clinically significant liver disease), obtained within 14 days prior to first treatment
Total bilirubin =< 1.5 x upper limit of normal, unless known Gilbert's syndrome
Total bilirubin =< 1.5 times upper limit of normal (ULN) institutional limits (unless Gilbert's disease)
Total bilirubin < 1.5 times upper limit of normal (ULN) institutional limits (unless Gilbert's disease)
Bilirubin =< 1.5 times the upper limit of normal (x ULN) for the institution or =< 3 mg/dl in a subject with Gilbert syndrome
Total bilirubin =< 1.5 x upper limit of normal (ULN) except for patients with known Gilbert syndrome
Total bilirubin =< 1.5 times upper limit normal (ULN) other than cases of Gilbert disease
Cohort A: Total bilirubin less than 1.5 x upper limit of normal (ULN) (unless known Gilbert's disease)
Bilirubin within 1.5 x the upper limit of normal for age, with the exception of those with Gilbert syndrome
Total bilirubin <1.5 x upper limit of normal (ULN), unless considered due to Gilbert's syndrome
Bilirubin less than or equal to 1.5 times the upper limit of normal (ULN) except for unconjugated hyperbilirubinemia of Gilbert's syndrome.
Total bilirubin =< 1.5 x upper limit of normal (ULN)\r\n* Except in case of Gilbert disease
Total bilirubin (TBL) < 1.5 × upper limit of normal (ULN; except for subjects with documented Gilbert's syndrome)
Bilirubin ?1.5 × upper limit of normal (ULN) except for unconjugated hyperbilirubinemia or Gilbert's syndrome;
Total bilirubin < 1.5 x upper limit of normal (ULN) (unless known Gilbert syndrome)
Total bilirubin =< 1.5 x upper limit of normal (ULN) (except for Gilbert's syndrome)
Serum bilirubin =< 1.5 x institutional upper limit of normal (ULN) (=< 3 x institutional ULN in patients with Gilbert's syndrome)
Total bilirubin < 1.5 × upper limit of normal (ULN); does not apply to patients with Gilbert's syndrome
Total bilirubin <1.5x the upper limit of normal unless considered due to Gilbert's syndrome in which case, <3x the upper limit of normal
Total serum bilirubin > 1.5 times upper limit of normal; increased serum bilirubin due to Gilbert's syndrome is permitted
Total bilirubin =< 1.5 x upper limit of normal (ULN) (unless known Gilbert's syndrome)
Bilirubin ?1.5 × upper limit of normal (ULN) except for unconjugated hyperbilirubinemia or Gilbert's syndrome.